No, not at the present time. However, using drugs to prevent KS may be possible in the near future. Given that KSHV has been shown to be a major culprit in the development of KS lesions, researchers are now looking at various antiviral drugs to see if they are effective against this virus. HIV-infected patients who are infected with KSHV and have low CD4+ cell counts may benefit greatly from these drugs, as they may prevent KS lesions from occurring in the first place.